THis study is intended to provide contemporary data on the burden of disease in patients 1 to 3 years post-MI, including a description of patient characteristics, current treatment patterns, rate of major CV events, and healthcare resource utilization in a 'real world' patient population at high atherothrombotic risk.
TIGRIS is a multinational, multi-centre, observational, prospective, longitudinal cohort study which will include stable CAD patients with history of MI 1-3 years ago and high risk of developing atherothrombotic events in a real world setting. The follow-up period is 3 years. Patients will undergo clinical assessments and receive standard medical care as determined by the treating physician. Patients will not receive experimental intervention or experimental treatment as a consequence of their participation in the study.
Study Type
OBSERVATIONAL
Enrollment
9,284
MI, unstable angina with urgent revascularization, stroke, and death for any cause
Event rates (time to first occurrence of any event from the composite of MI, unstable angina with urgent revascularization, stroke or death for any cause) in a three-year follow-up period.
Time frame: in a 3-year follow-up period
Healthcare resource utilization
Healthcare resource utilization associated with the events (MI, unstable angina with urgent revascularization, stroke or death for any cause) in a three-year follow-up period.
Time frame: in a 3-year follow-up period
Ischemic events (MI, unstable angina with urgent revascularization, ischemic stroke, CV death or death with unknown reason)
To describe the rate of ischemic events (time to first occurrence of any event from the composite of MI, unstable angina with urgent revascularization, ischemic stroke, CV death or death with unknown reason) in a three-year follow-up period.
Time frame: in a 3-year follow-up period
Bleeding events which require medical attention
To describe the rate of bleeding events requiring medical attention.
Time frame: in a 3 year follow-up period
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Research Site
Huntsville, Alabama, United States
Research Site
Los Angeles, California, United States
Research Site
Santa Ana, California, United States
Research Site
Torrance, California, United States
Research Site
Ventura, California, United States
Research Site
Clearwater, Florida, United States
Research Site
Miami, Florida, United States
Research Site
Tallahassee, Florida, United States
Research Site
Tucker, Georgia, United States
Research Site
Arlington Heights, Illinois, United States
...and 299 more locations